Aptivus (Tipranavir) for HIV

Overview
Aptivus is a prescription drug approved by the Food and Drug Administration (FDA) to treat HIV-1 infection in combination with Norvir (Ritonavir). Aptivus can be used by people who have already begun treatment for HIV and who are infected with HIV strains that are resistant to multiple protease inhibitors. Aptivus is also referred to by its drug name, Tipranavir, and by the abbreviation TPV. Aptivus is an antiviral medication of the protease inhibitor (PI) class. Aptivus is believed to work by preventing HIV from replicating in cells.

How do I take it?
Prescribing information states that Aptivus is taken twice daily. Aptivus comes in capsule and oral solution forms.

Side effects
The FDA-approved label for Aptivus lists common side effects including headache, nausea, diarrhea, vomiting, stomach pain, sleepiness, dizziness, and changes in the shape or location of body fat. Rare but serious side effects listed for Aptivus include liver failure and intercranial hemorrhage.

For more details about this treatment, visit:

Aptivus – RxList

Overview of HIV Treatments – AIDS.gov